U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Kiru G, Bicknell C, Falaschetti E, et al.; on behalf of the AARDVARK collaborators. An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK). Southampton (UK): NIHR Journals Library; 2016 Jul. (Health Technology Assessment, No. 20.59.)

Cover of An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK)

An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK).

Show details

Appendix 8Histograms of change in abdominal aortic aneurysm longitudinal internal measurements

FIGURE 44. Histograms of change in AAA longitudinal internal diameter from baseline to month 3.
FIGURE 44. Histograms of change in AAA longitudinal internal diameter from baseline to month 3.
FIGURE 44. Histograms of change in AAA longitudinal internal diameter from baseline to month 3.
FIGURE 44. Histograms of change in AAA longitudinal internal diameter from baseline to month 3.

FIGURE 44

Histograms of change in AAA longitudinal internal diameter from baseline to month 3. (a) Placebo; (b) perindopril; (c) amlodipine; and (d) total.

FIGURE 45. Histograms of change in AAA longitudinal internal diameter from baseline to month 6.
FIGURE 45. Histograms of change in AAA longitudinal internal diameter from baseline to month 6.
FIGURE 45. Histograms of change in AAA longitudinal internal diameter from baseline to month 6.
FIGURE 45. Histograms of change in AAA longitudinal internal diameter from baseline to month 6.

FIGURE 45

Histograms of change in AAA longitudinal internal diameter from baseline to month 6. (a) Placebo; (b) perindopril; (c) amlodipine; and (d) total.

FIGURE 46. Histograms of change in AAA longitudinal internal diameter from baseline to month 12.
FIGURE 46. Histograms of change in AAA longitudinal internal diameter from baseline to month 12.
FIGURE 46. Histograms of change in AAA longitudinal internal diameter from baseline to month 12.
FIGURE 46. Histograms of change in AAA longitudinal internal diameter from baseline to month 12.

FIGURE 46

Histograms of change in AAA longitudinal internal diameter from baseline to month 12. (a) Placebo; (b) perindopril; (c) amlodipine; and (d) total.

FIGURE 47. Histograms of change in AAA longitudinal internal diameter from baseline to month 18.
FIGURE 47. Histograms of change in AAA longitudinal internal diameter from baseline to month 18.
FIGURE 47. Histograms of change in AAA longitudinal internal diameter from baseline to month 18.
FIGURE 47. Histograms of change in AAA longitudinal internal diameter from baseline to month 18.

FIGURE 47

Histograms of change in AAA longitudinal internal diameter from baseline to month 18. (a) Placebo; (b) perindopril; (c) amlodipine; and (d) total.

FIGURE 48. Histograms of change in AAA longitudinal internal diameter from baseline to month 24.
FIGURE 48. Histograms of change in AAA longitudinal internal diameter from baseline to month 24.
FIGURE 48. Histograms of change in AAA longitudinal internal diameter from baseline to month 24.
FIGURE 48. Histograms of change in AAA longitudinal internal diameter from baseline to month 24.

FIGURE 48

Histograms of change in AAA longitudinal internal diameter from baseline to month 24. (a) Placebo; (b) perindopril; (c) amlodipine; and (d) total.

Copyright © Queen’s Printer and Controller of HMSO 2016. This work was produced by Kiru et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.

Included under terms of UK Non-commercial Government License.

Bookshelf ID: NBK378840
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (14M)

Other titles in this collection

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...